Up a level |
Lee, RJ, Wysocki, O, Bhogal, T ORCID: 0000-0003-3297-9957, Shotton, R, Tivey, A, Angelakas, A, Aung, T, Banfill, K, Baxter, M, Boyce, H et al (show 30 more authors)
(2021)
Erratum to "Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome".
ESMO OPEN, 6 (2).
100056-.
Lee, RJ, Zhou, C ORCID: 0000-0002-6938-4685, Wysocki, O ORCID: 0000-0002-7053-4919, Shotton, R ORCID: 0000-0003-4545-8296, Tivey, A ORCID: 0000-0002-5389-3741, Lever, L, Woodcock, J, Angelakas, A ORCID: 0000-0002-9769-9940, Aung, T, Banfill, K ORCID: 0000-0003-1832-548X et al (show 36 more authors)
(2020)
Establishment of CORONET; COVID-19 Risk in Oncology Evaluation Tool to identify cancer patients at low versus high risk of severe complications of COVID-19 infection upon presentation to hospital.
MedRxiV.
Lee, RJ, Wysocki, O, Bhogal, T ORCID: 0000-0003-3297-9957, Shotton, R, Tivey, A, Angelakas, A, Aung, T, Banfill, K, Baxter, M, Boyce, H et al (show 30 more authors)
(2021)
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.
ESMO OPEN, 6 (1).
100005-.
Whitehead, I, Irwin, GW, Bannon, F, Coles, CE, Copson, E, Cutress, RI, Dave, RV, Gardiner, MD, Grayson, M, Holcombe, C et al (show 9 more authors)
(2021)
The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making.
BMC CANCER, 21 (1).
90-.
Irwin, GW, Bannon, F, Coles, CE, Copson, E, Cutress, RI, Dave, RV, Grayson, M, Holcombe, C, Irshad, S, O'Brien, C et al (show 8 more authors)
(2019)
The NeST (neoadjuvant systemic therapy in breast cancer) study - Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer.
INTERNATIONAL JOURNAL OF SURGERY PROTOCOLS, 18.
pp. 5-11.